Leadership had an opportunity to build support and consolidate...

Leadership had an opportunity to build support and consolidate at the high prices with the announcement of the Akida validation. LTH were waiting years for the chip to be validated and all they got was a couple of fluffy paragraphs - it didn't cut it and left too much uncertainty. A slick report with detailed testing results, a list of early access customers that will be receiving the chips (if NDA allowed), what is expected for production, a detailed roadmap to commercialisation and market size and growth estimates is what was needed to substantiate the high valuation.

BRN have a genius product but they need to be able to sell. It will be concerning at the summit if they don't have Global Head of Sales, Rob Telson, leading the presentations. Judging by previous presentations, if it is delivered in the same way it will be another fizzer. This has been my key concern with the company since investing.

Happy with the profit since buying in but will be back in when there is some solid traction in sales and delivery. GL all.